Wild-type p53 gene transfer: A novel therapeutic strategy for neointimal hyperplasia after arterial injury

Annals of the New York Academy of Sciences

Volumn 811, Issue , 1997, Pages 395-400

  Yonemitsu, Yoshikazu ^a,c   Kaneda, Yasufumi ^b   Hata, Yasuaki ^a   Nakashima, Yutaka ^a   Sueishi, Katsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DOXORUBICIN; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; CATTLE; CELL CYCLE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CONFERENCE PAPER; CONTROLLED STUDY; DNA SYNTHESIS; EXPRESSION VECTOR; GENE THERAPY; GENE TRANSFER; NONHUMAN; RABBIT; VASCULAR SMOOTH MUSCLE;

ANIMALIA; BOS TAURUS; ORYCTOLAGUS CUNICULUS;

EID: 0030803981     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb52019.x     Document Type: Conference Paper

References (13)

1. EL-DEIRY, W. S., T. TORINO, V. E. VELCULESCU, D. B. LEVY, R. PARSONS, J. M. TRENT, D. LIN, W. E. MERCER, K. W. KINZLER & B. VOGELSTEIN. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
2. HARPER, J. W., G. R. ADAMI, N. WEI, K. KEYOMARSI & S. J. ELLEDGE. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
3. SPAIR, E., R. MODALI, E. HUANG, M. B. LEON, F. SHAWL, T. FINKEL & S. E. EPSTEIN. 1994. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265: 391-394.
4. YONEMITSU, Y., Y. KANEDA, K. KOMORI, K. HIRAI, K. SUGIMACHI & K. SUEISHI. 1997. The immediate early gene of human cytomegalovirus stimulates vascular smooth muscle cell proliferation in vitro and in vivo. Biochem. Biophys. Res. Comm. In press.
5. LOWE, S. W., H. E. RULEY, T. JACKS & D. E. HOUSMAN. 1993. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967.
6. KANEDA, Y., K. IWAI & T. UCHIDA. 1989. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 243: 375-378.
7. MORISHITA, R., G. H. GIBBONS, K. E. ELLISON, M. NAKAJIMA, L. ZHANG, Y. KANEDA, T. OGIHARA & V. J. DZAU. 1993. Novel intraluminal molecular delivery of antisense cdc2 kinase and PCNA oligonucleotide results in chronic inhibition of neointimal hyperplasia. Proc. Natl. Acad. Sci. USA 90: 8474-8478.
8. YONEMITSU, Y., Y. KANEDA, R. MORESHITA, K. NAKAGAWA, Y. NAKASHIMA & K. SUEISHI. 1996. Characterization of in vivo gene transfer into the arterial wall mediated by the Sendai virus (HVJ) liposomes: an effective tool for the in vivo study of arterial diseases. Lab. Invest. 75: 313-323.
9. SARAC, T. P., P. N. RIGGS, J. P. WILLIAMS, R. H. FEINS, R. BAGGS, P. RUBIN & R. M. GREEN. 1995. The effects of low-dose radiation on neointimal hyperplasia. J. Vasc. Surg. 22: 17-24.
10. WAKSMAN, R., K. A. ROBINSON, I. R. CROCKER, M. B. GRAVANIS, S. J. PALMER, C. WANG, G. D. CIPOLLA & S. B. KING III. 1995. Intracoronary radiation before stent implantation inhibits neointimal formation in stented porcine coronary arteries. Circulation 92: 1383-1386.
11. HEHRLEIN, C., C. GOLLAN, K. DONGES, J. METZ, R. REISSEN, P. FEHSENFELD, E. VON HODENBERG & W. KUBER. 1995. Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. Circulation 92: 1570-1575.
12. KASTEN, M. B., O. ONYEKWERE, D. SIDRANSKY, B. VOGELSTEIN & R. W. CRAIG. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51: 6304-6311.
13. KUERBITZ, S. J., B. S. PLUNKETT, W. V. WALSH & M. B. KASTEN. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89: 7491-7495.